Menu Search
Equities

Becton Dickinson and Co

BDX:NYQ

Becton Dickinson and Co

Actions
Health CareMedical Equipment and Services
  • Price (USD)225.48
  • Today's Change1.48 / 0.66%
  • Shares traded1.00
  • 1 Year change-5.61%
  • Beta0.4222
Data delayed at least 15 minutes, as of Nov 26 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy7
Outperform8
Hold3
Sell0
Strong Sell0

Share price forecast in USD

The 15 analysts offering 12 month price targets for Becton Dickinson and Co have a median target of 275.00, with a high estimate of 327.54 and a low estimate of 249.98. The median estimate represents a 21.96% increase from the last price of 225.48.
High45.3%327.54
Med22.0%275.00
Low10.9%249.98

Dividends in USD

In 2024, Becton Dickinson and Co reported a dividend of 3.80 USD, which represents a 4.40% increase over last year. The 6 analysts covering the company expect dividends of 3.97 USD for the upcoming fiscal year, an increase of 4.55%.
Div growth (TTM)4.40%
More ▼

Earnings history & estimates in USD

On Nov 07, 2024, Becton Dickinson and Co reported 4th quarter 2024 earnings of 3.81 per share. This result was in line with the consensus of the 14 analysts following the company and exceeded last year's 4th quarter results by 11.40%.
The next earnings announcement is expected on Feb 06, 2025.
Average growth rate+3.98%
Becton Dickinson and Co reported annual 2024 earnings of 13.14 per share on Nov 07, 2024.
Average growth rate+12.85%
More ▼

Revenue history & estimates in USD

Becton, Dickinson and Company had 4th quarter 2024 revenues of 5.44bn. This bettered the 5.38bn consensus of the 12 analysts covering the company. This was 18.56% above the prior year's 4th quarter results.
Average growth rate+1.87%
Becton, Dickinson and Company had revenues for the full year 2024 of 20.25bn. This was 4.51% above the prior year's results.
Average growth rate+6.21%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.